Teva Pharmaceutical Industries Limited reported unaudited consolidated impairment charges for the second quarter ended June 30, 2025. For the quarter, the company reported intangible assets impairments of $42,000 as compared to $61,000 a year ago; Impairment of long-lived assets of $99,000 as compared to $130,000 a year ago.